background logo image

Episode 216

Dr. Eric Westman on the Future of Metabolic Medicine

Listen, Watch & Subscribe on:

Watch

Dr. Eric Westman on the Future of Metabolic Medicine

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

About the guest

Eric Westman

Eric Westman

Board-Certified in Internal Medicine and Obesity Medicine; Associate Professor

Eric Westman

Board-Certified in Internal Medicine and Obesity Medicine; Associate Professor

Dr. Eric Westman is a board-certified internal medicine physician and Associate Professor of Medicine at Duke University. His clinical and research work has focused extensively on low-carbohydrate and ketogenic nutrition for obesity and metabolic health.
Learn more about Eric

Key Highlights

  • Dr. Eric Westman reflects on watching the Cholesterol Code documentary, describing Dave Feldman’s journey from self-experimenting with his own cholesterol to eventually crowdfunding research after mainstream academics dismissed his interest in studying elevated LDL on low-carb diets.
  • He argues doctors often fixate on a modest LDL increase while overlooking much larger, more clinically significant benefits like reversing type 2 diabetes, arguing this represents a misdirection of clinical focus.
  • Dr. Westman highlights that the documentary featured coronary CT angiograms showing people with elevated LDL on low-carb diets had no significant arterial plaque, offering direct evidence beyond just symptom improvement.
  • He compares the risk magnitude of diabetes, obesity, and smoking on heart disease to that of smoking and lung cancer, arguing LDL’s contribution is comparatively minor and shouldn’t override efforts to reverse more significant metabolic diseases.
  • On GLP-1 medications, Westman argues both drugs and lifestyle interventions have a role, but stresses that without addressing diet and lifestyle, patients risk regaining weight once medications stop, since it’s ultimately the weight loss and dietary changes, not the drug itself, driving many of the improvements seen.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

Triglycerides Down, Plaque Unchanged: What This Trial Reveals
Podcast

Triglycerides Down, Plaque Unchanged: What This Trial Reveals

Dr. Bret Scher examines a new trial showing the drug olezarsen dramatically lowered triglycerides and ApoB, yet produced zero reduction in coronary artery plaque. He uses this as a case study for a broader point: lowering a lab number with a drug isn't the same as fixing the underlying metabolic dysfunction that caused it, drawing parallels to blood sugar, blood pressure, and weight management medications.

Read more

High Cholesterol on Keto? Here’s One Psychiatrist’s Approach
Podcast

High Cholesterol on Keto? Here’s One Psychiatrist’s Approach

Dr. Lori Calabrese shares a case study of a 29-year-old schizophrenia patient whose LDL climbed sharply on ketogenic metabolic therapy while nearly every other metabolic marker dramatically improved, allowing her to taper off antipsychotic medication. Rather than stopping the diet or dismissing the lipid changes, Calabrese tracked serial labs, investigated family history, and eventually looped in cardiology, illustrating why psychiatrists using metabolic therapies need working knowledge across specialties.

Learn more

Early Heart Disease Detection? Why You May Consider a CIMT Test
Videos

Early Heart Disease Detection? Why You May Consider a CIMT Test

Why should we rely on a blood test to assess heart disease risk when we can see the disease itself? Transcript: Introduction to Carotid Intima-Media Thickness test (CIMT).Have…

Learn more

Journal of clinical lipidology
News

Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research

A cautious, and nuanced editorial about elevated LDL cholesterol while on a keto diet. Read more here!

Learn more

Triglycerides Down, Plaque Unchanged: What This Trial Reveals
Podcast

Triglycerides Down, Plaque Unchanged: What This Trial Reveals

Dr. Bret Scher examines a new trial showing the drug olezarsen dramatically lowered triglycerides and ApoB, yet produced zero reduction in coronary artery plaque. He uses this as a case study for a broader point: lowering a lab number with a drug isn't the same as fixing the underlying metabolic dysfunction that caused it, drawing parallels to blood sugar, blood pressure, and weight management medications.

Read more

High Cholesterol on Keto? Here’s One Psychiatrist’s Approach
Podcast

High Cholesterol on Keto? Here’s One Psychiatrist’s Approach

Dr. Lori Calabrese shares a case study of a 29-year-old schizophrenia patient whose LDL climbed sharply on ketogenic metabolic therapy while nearly every other metabolic marker dramatically improved, allowing her to taper off antipsychotic medication. Rather than stopping the diet or dismissing the lipid changes, Calabrese tracked serial labs, investigated family history, and eventually looped in cardiology, illustrating why psychiatrists using metabolic therapies need working knowledge across specialties.

Learn more

Early Heart Disease Detection? Why You May Consider a CIMT Test
Videos

Early Heart Disease Detection? Why You May Consider a CIMT Test

Why should we rely on a blood test to assess heart disease risk when we can see the disease itself? Transcript: Introduction to Carotid Intima-Media Thickness test (CIMT).Have…

Learn more

Journal of clinical lipidology
News

Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research

A cautious, and nuanced editorial about elevated LDL cholesterol while on a keto diet. Read more here!

Learn more